| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966308 | Vaccine | 2013 | 9 Pages |
Abstract
Vaccinating pre-adolescent girls against HPV is predicted to be highly cost-effective. If equally priced, the quadrivalent is the most economically desirable vaccine. However, ultimately, the most cost-effective HPV vaccine will be determined by their relative price.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Marc Brisson, Jean-François Laprise, Mélanie Drolet, Nicolas Van de Velde, Eduardo L. Franco, Erich V. Kliewer, Gina Ogilvie, Shelley L. Deeks, Marie-Claude Boily,